Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Everolimus Therapy for Epilepsy in Tuberous Sclerosis Complex
NCT01070316Phase 2Completed
- Sponsor
- Cincinnati Children's Hospital Medical Center
- Start
- Jan 2010
- Primary completion
- Apr 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of everolimus in epilepsy, tuberous sclerosis complex (TSC), sponsored by Cincinnati Children's Hospital Medical Center. Started Jan 2010; status: completed.
02
Drugs
everolimus
03
Conditions
epilepsytuberous sclerosis complex (TSC)
Beyond the preview
Go deeper on NCT01070316.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01070316.